Monthly Archives: November 2010

Thousands of the 93,000 people who received artificial hips made by DePuy Orthopedics will have to have surgery to have their implants replaced because the products can dislocate, come loose, or cause bone fractures. The affected parts include the ASR ... Read More

The U.S. Senate today passed a sweeping overhaul of the country’s food safety system, a move triggered by the steadily growing number of food-borne illness outbreaks occurring throughout the country. If signed into law, the Food Safety Modernization Act will ... Read More

Merck announced it will end a study of its HIV drug Isentress after early results showed that a once-daily treatment was less effective than the currently approved twice-daily dosage. The once-daily version would have been a convenient option to HIV-positive ... Read More

A federal judge in Santa Ana, California dealt Toyota a major legal blow when he rejected the automaker’s petition to have all class-action lawsuits seeking damages related to sudden-unintended-acceleration (SUA) issues thrown out. ... Read More

According to National Geographic magazine, scientists discovered a massive deep-sea coral die-off this month about 7 miles southwest of the site where BP’s blown-out well spewed millions of gallons of crude oil for months. ... Read More

A report in the Pittsburgh Post-Gazette demonstrates the considerable costs to society when commercial trucking companies fail to take industry rules and regulations seriously. On Thursday, the paper reported that a driver who ignored a sign on Interstate 70 just ... Read More

The Food and Drug Administration (FDA) will take more time to decide whether to approve Merck KGaA’s Cladribine, an oral medication to treat relapsing forms of multiple sclerosis (MS). The agency had given the drug Priority Review status in July, ... Read More

Cochlear implants used to provide a sense of sound to people who are profoundly deaf or hard of hearing are being recalled by the manufacturer because the devices may malfunction and cause recipients to experience severe pain, overly loud sounds, and/or shocking sensations 8-10 days after the device was activated. ... Read More

The Food and Drug Administration (FDA) has cleared the way for clinical trials to begin on a therapy derived from human embryonic stem cells designed to treat children with a form of macular degeneration known as Stargardt’s macular dystrophy. This ... Read More

The Federal Motor Carrier Safety Administration has announced revisions to its Comprehensive Safety Analysis (CSA) 2010 safety measurement program, the federal initiative designed to improve large truck and bus safety and reduce the number of commercial motor vehicle (CMV)-related crashes, ... Read More